Latest filing published 28 Aug 2026 for Orchestra BioMed Holdings, Inc., €915.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Joshua Aiello is a declared insider of Orchestra BioMed Holdings, Inc., with filings sourced from SEC (Form 4). Between 20 July 2023 and 26 August 2026, the trades on record add up to 8 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 28 August 2026, reports a share grant of €915 in Orchestra BioMed Holdings, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations